<scp>PCBP2</scp> Regulates <scp> p16 <sup>INK4a</sup> </scp> ‐Dependent Cellular Senescence in Response to Iron
Recently, we have identified rs1333046 as one of the candidate functional single nucleotide polymorphisms (fSNPs) on the atherosclerosis-associated CDKN2A/B locus. However, how rs1333046 influences the pathogenesis of and susceptibility to atherosclerosis is unknown. In this work, we demonstrate that rs1333046 is part of a cis-regulatory element (cis-RE) that regulates p16<sup>INK4a</sup> and p16<sup>INK4a</sup>-dependent cellular senescence in human endothelial cells (ECs). This is achieved by recruiting poly(rC)-binding protein 2 (PCBP2), a member of the poly-cytosine binding protein family. We also reveal that PCBP2 is an upstream regulator of CD40, which regulates the expression of senescence-associated secretory phenotype (SASP) genes through NF-κB signaling. Moreover, consistent with PCBP2 being an iron chaperone, we discover that iron can induce cellular senescence by regulating both p16<sup>INK4a</sup> and CD40-mediated SASP gene expression through PCBP2. Notably, iron dynamically regulates p16<sup>INK4a</sup> expression by altering the binding of PCBP2 to rs1333046. In addition, reducing intracellular labile iron by overexpressing both iron storage protein ferritin light chain (FTL) and iron exporter ferroportin 1 (FPN1) in ECs suppresses cellular senescence, and overexpression of PCBP2 in both FTL- and FPN1-overexpressing cells restores cellular senescence. Thus, our studies suggest that iron could be a potential environmental factor regulating atherosclerosis-associated cellular senescence, and this is achieved by modulating PCBP2-dependent p16<sup>INK4a</sup> and CD40 expression. This study shows the mechanism by which iron affects the pathology of atherosclerosis.
Authors
- Ebin Johny (ORCID: https://orcid.org/0000-0002-8857-9357)
- Zhaoyu Du
- Partha Dutta (ORCID: https://orcid.org/0000-0001-7456-1757)
- Shaoyang Yan
- Gang Li (ORCID: https://orcid.org/0000-0003-1725-6611)
- Lili Lu (ORCID: https://orcid.org/0000-0002-0372-9716)
- Yuwei Wu (ORCID: https://orcid.org/0009-0001-1717-8572)
Institutions
- Hebei Medical University (CN)
- University of Pittsburgh (US)
- UPMC Hillman Cancer Center (US)
- University of Pittsburgh Medical Center (US)
- First Affiliated Hospital of Hebei Medical University (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- Aging Cell
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1111/acel.70283
- Primary Topic
- Telomeres, Telomerase, and Senescence
- Type
- article
- Field-Weighted Citation Impact
- 0.00